Aliskiren
CSPP100A2368
Phase 3 small_molecule completed
Quick answer
Aliskiren for Acute Decompensated Heart Failure is a Phase 3 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Acute Decompensated Heart Failure
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed